Justin M. Hall
2018 - NovaBay Pharmaceuticals
In 2018, Justin M. Hall earned a total compensation of $572.2K as Interim President and CEO GC and Chief Compliance Officer at NovaBay Pharmaceuticals, a 14% decrease compared to previous year.
Compensation breakdown
| Option Awards | $311,499 |
|---|---|
| Salary | $260,000 |
| Other | $660 |
| Total | $572,159 |
Hall received $311.5K in option awards, accounting for 54% of the total pay in 2018.
Hall also received $260K in salary and $660 in other compensation.
Rankings
In 2018, Justin M. Hall's compensation ranked 11,443rd out of 14,244 executives tracked by ExecPay. In other words, Hall earned more than 19.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,443 out of 14,244 | 20th |
Division Manufacturing | 4,624 out of 5,765 | 20th |
Major group Chemicals And Allied Products | 1,754 out of 2,128 | 18th |
Industry group Drugs | 1,491 out of 1,817 | 18th |
Industry Pharmaceutical Preparations | 1,145 out of 1,391 | 18th |
Source: SEC filing on April 19, 2019.
Hall's colleagues
We found three more compensation records of executives who worked with Justin M. Hall at NovaBay Pharmaceuticals in 2018.
News
NovaBay Pharmaceuticals CEO Justin Hall's 2021 pay rises 6% to $796K
March 30, 2022
NovaBay Pharmaceuticals CEO Justin Hall's 2020 pay jumps 129% to $747K
April 7, 2021
NovaBay Pharmaceuticals CFO Jason Raleigh receives $334K in 2019
April 15, 2020
YRC Worldwide CEO Darren Hawkins' 2018 pay jumps 439% to $4.4M
April 25, 2019
NovaBay Pharmaceuticals CEO John McGovern's 2018 pay jumps 64% to $742K
April 19, 2019